CARISOPRODOL TABLETS
Generic: CARISOPRODOL
Granulation TechnologyManufacturer
ORALRoute
CARISOPRODOLActive Substance
2021-10-20Original Approval
CARISOPRODOL TABLETS is FDA application ANDA211789, sponsored by POINTVIEW HLDINGS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
COMPLETED SUICIDE
1,420 reports
2
TOXICITY TO VARIOUS AGENTS
814 reports
3
CHRONIC KIDNEY DISEASE
550 reports
4
CARDIAC ARREST
548 reports
5
RESPIRATORY ARREST
532 reports
6
PAIN
496 reports
7
DRUG ABUSE
429 reports
8
DEATH
411 reports
9
DRUG INEFFECTIVE
404 reports
10
NAUSEA
396 reports